Peter Wirth

Peter Wirth is an accomplished executive in the biopharmaceutical and life sciences sectors, currently serving as Chairman of Syros Pharmaceuticals, Inc. since January 2017 and Director at Zai Lab Limited since August 2017. Wirth has held significant leadership roles including Chairman of FORMA Therapeutics, Inc. until October 2022, Executive Chairman at ZappRx, Inc. from August 2016 to May 2018, and Director at Aura Biosciences, Inc. and Synageva BioPharma Corp. Wirth co-founded Lysosomal Therapeutics, Inc. and was a senior executive at Genzyme Corporation from 1996 to 2011. Additionally, Wirth practiced law as a Partner and Chairman of the Technology Group at Palmer & Dodge LLP from 1975 to 1996. Wirth holds a Juris Doctor degree, cum laude, from Harvard Law School and a Bachelor of Arts degree from the University of Wisconsin-Madison, with further education at Albert Ludwigs Universität in Germany.